1. A randomized phase II trial on neoadjuvant chemotherapy in resectable pancreatic adenocarcinoma. Issue 4 (April 2018) Authors: Balzano, G.; Zanon, S.; Castoldi, R.; Aleotti, F.; Zerbi, A.; Falconi, M.; Andreasi, V.; Gianni, L.; Nicoletti, R.; Reni, M. Journal: European journal of surgical oncology Issue: Volume 44:Issue 4(2018) Page Start: 553 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PO-1225 Hypofractionated radiotherapy after induction chemotherapy for advanced pancreatic cancer. (August 2021) Authors: Passoni, P.; Broggi, S.; Slim, N.; Longobardi, B.; Mori, M.; Peretti, U.; Macchini, M.; Orsi, G.; Balzano, G.; Castoldi, R.; Falconi, M.; Del Vecchio, A.; Cattaneo, G.M.; Fiorino, C.; Cascinu, S.; Reni, M.; Di Muzio, N.G. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S1013 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Postoperative outcomes and functional recovery after neoadjuvant chemotherapy for pancreatic cancer: A propensity score-matched study. Issue 12 (December 2020) Authors: Pecorelli, N.; Pagnanelli, M.; Belfiori, G.; Delpini, R.; Cinelli, L.; Tamburrino, D.; Crippa, S.; Partelli, S.; Castoldi, R.; Reni, M.; Falconi, M.; Balzano, G. Journal: European journal of surgical oncology Issue: Volume 46:Issue 12(2020) Page Start: e8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗